Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 5Gastrointestinal Stromal Tumors 3Stomach Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Colonic Neoplasms 2Bone Neoplasms 2Bile Duct Neoplasms 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Skin Neoplasms 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neurofibrosarcoma 1Neoplasms, Connective and Soft Tissue 1Malignant mesenchymal tumor 1Lymphoma 1Lung Neoplasms 1Liver Neoplasms 1Liposarcoma 1Leukemia 1Leiomyosarcoma 1Laryngeal Neoplasms 1

Interventions

Ifosfamide 8Doxorubicin 8Radiotherapy 6Chemotherapy, Adjuvant 4Neoadjuvant Therapy 3Filgrastim 3Vincristine 2Trabectedin 2Etoposide 2Epirubicin 2Dactinomycin 2Cyclophosphamide 2Carboplatin 2vatalanib 1soblidotin 1romidepsin 1perifosine 1indolepropanol phosphate 1exatecan 1cixutumumab 1brostallicin 1Watchful Waiting 1Temozolomide 1Sunitinib 1Sorafenib 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Observation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemangiopericytoma, Malignant × Observation × Sarcoma × Clear all
NCT00346164 2022-04-28

Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma

Children's Oncology Group

Phase 3 Completed
588 enrolled 22 charts
Sarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Dermatofibrosarcoma, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡